Filer Snapshot

Redmile Group, LLC

CIK 0001425738. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

150

Latest filing

15 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

SRRK

$445.72M reported value

Open holding

13D/G large stake

ATRA

12 May 2026 · 9.9% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Schedule 13D/G

SCHEDULE 13G filed on 15 May 2026 for CIK 0001425738.

View Source Filing
Ownership signals 1 signal
Ownership signals

SEC value by filing type

Compare filing types separately; 13F, 13D/G, and Forms 3/4/5 are different evidence sources.

Latest 13F portfolio$1.51B

Quarterly institutional portfolio holdings.

Forms 3/4/5 positions$406.88M

Reporting-owner positions with enough data to estimate value.

Latest 13F portfolio value

$1.51B

Market value from the latest parsed Form 13F portfolio.

Estimated Forms 3/4/5 position value

$406.88M

Estimated only when owner filings include enough share and price data.

Largest 13F positions

SRRK KRYS STOK IMNM NRIX
+15 moreANNX ADCT RGNX STTK BEAM NGNE COGT ABSI IDYA ALXO FATE XENE SLDB NUVB ZYME

Largest symbols in the latest parsed 13F information table.

Largest linked SEC positions

Largest issuer positions found across parsed 13F, 13D/G, and Forms 3/4/5 data.

RYZB ADCT ABSI FATE TRDA ZYME VERV IVVD
+2 moreSTTK ATRA

Largest 13F positions

Largest symbols in the latest parsed Form 13F information table.

SRRK KRYS STOK IMNM NRIX ANNX ADCT RGNX
+12 moreSTTK BEAM NGNE COGT ABSI IDYA ALXO FATE XENE SLDB NUVB ZYME

Schedule 13D positions

Active large-stake positions disclosed in parsed Schedule 13D filings.

ABSI FATE ATRA STTK IGMS

Schedule 13G positions

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

SRRK NRIX STOK IMNM FOLD ANNX
+12 moreZYME ADCT REPL RGNX NGNE ALXO RAPT ATRA PLRX GRTS AgomAb Therapeutics NV SLN
How to read these SEC values
  • Read each filing type on its own: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different questions.
  • Open the linked research paths when you need to verify the exact SEC filing behind a value.
Identity 1 identity field
Business address
900 Larkspur Landing Circle, Suite 270, Larkspur, CA, 94939
SEC profile 2 profile fields
State of incorporation
DE
Fiscal year-end
31 December

Filer intelligence

What SEC filings say about Redmile Group, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $1.51B across 35 reported holdings for Q1 2026.
  • Largest parsed 13F holding: SRRK at $445.72M.
  • 5 recent 13D/G stake rows found; top row is ATRA at 9.9% ownership.
  • Forms 3/4/5 show insider context for RYZB worth $116.11M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 35 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 5 rows

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 15 May 2026

Top 5 concentration

66%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$996.71M

Compared with $1.51B total 13F value.

Top 5 net change

+$183.12M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: SRRK · Largest trim: RAPT

SRRK KRYS STOK IMNM NRIX Other holdings

SRRK

29.5%

Scholar Rock Hldg Corp

$445.72M

KRYS

11.5%

Krystal Biotech Inc

$173.98M

STOK

9%

Stoke Therapeutics Inc

$135.58M

IMNM

8.1%

Immunome Inc

$121.57M

NRIX

7.9%

Nurix Therapeutics Inc

$119.86M

13D/G large-stake context

ATRA

12 May 2026 · Common Stock, par value $0.0001 per share

9.9%

FATE

20 Apr 2026 · Common Stock, par value $0.001 per share

15%

NRIX

20 Apr 2026 · Common Stock, par value $0.001 per share

9.9%

ADCT

20 Apr 2026 · Common Shares, par value CHF 0.08 per share

9.9%

Forms 3/4/5 insider context

RYZB

19 Sep 2023 · 10% owner

$116.11M

ADCT

31 Mar 2026 · 10% owner

$105.19M

ABSI

12 Jun 2024

$41.14M

FATE

20 Apr 2026 · 10% owner

$39.56M

Latest update

What changed recently for Redmile Group, LLC

New filing available

Latest 13F period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

15 May 2026

Page type

Filer profile

Latest period

Q1 2026

Institutional portfolio context was refreshed from a 13F filing filed on 15 May 2026.

Benchmark Context

Benchmark context for this company

Redmile Group, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest 13F period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001425738 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
150
First seen
14 Feb 2014
Latest filing
15 May 2026
Entity
Company

Observed form types

13F-HR 13F-HR/A 3 4 4/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A

Latest Filings

Showing the latest 12 of 150 SEC filings for Redmile Group, LLC.

SCHEDULE 13G

SCHEDULE 13G filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
22 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
14 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
06 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .